Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Neoplasms 4Breast Neoplasms 4Neoplasm Metastasis 3Lung Neoplasms 3Triple Negative Breast Neoplasms 2Multiple Myeloma 2Lymphoma 2Glioblastoma 2Colorectal Neoplasms 2Stroke 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neurologic Manifestations 1Myelodysplastic Syndromes 1Motor Activity 1Melanoma 1Margins of Excision 1Malignant Solid Neoplasm 1Malignant Female Reproductive System Neoplasm 1Localized Head and Neck Carcinoma 1Leukemia, Myeloid, Acute 1Leukemia 1Inflammatory Breast Neoplasms 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Depression 1Communication 1

Interventions

fludarabine 26Cyclophosphamide 21Azacitidine 20venetoclax 18Specimen Handling 18fludarabine phosphate 17Whole-Body Irradiation 14Mycophenolic Acid 14Melphalan 14Busulfan 14Biopsy 14Tacrolimus 12Cytarabine 12Granulocyte Colony-Stimulating Factor 10decitabine and cedazuridine drug combination 9Decitabine 9Stem Cell Transplantation 8Sirolimus 8Peripheral Blood Stem Cell Transplantation 8Injections 8Filgrastim 8Cyclosporine 8Thiotepa 6ruxolitinib 5X-Rays 5Idarubicin 5CPX-351 5Magnetic Resonance Spectroscopy 4Cladribine 411-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic Syndromes × Palliative Care × 90 days × Clear all
NCT03310918 2026-04-06

A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy

Massachusetts General Hospital

Phase NA Active not recruiting
320 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡